academyactivityanifrolumabannualbelimumabbiomarkercarechildhoodclinicalcognitivecoviddiseasedysfunctioneffectsefficacyerythematosusfirsthighhighlightsimmunityimpactinsightsjournallearningmachinemanagingmaymeasuremeetingnephritisoutcomespatientpatientspotentialpregnancyriskrituximabrnasesafetysevereslesystemictestingtherapeutictissuetreatmenttrialstypeunderstandinguseusingvalidating